Lupus drug may shield against COVID-19, study finds

NCT ID NCT04481633

First seen Jan 04, 2026 · Last updated Jun 12, 2026 · Updated 22 times

Summary

This study looked at whether hydroxychloroquine, a drug already used for lupus, could help prevent COVID-19 or make it less severe. Researchers followed 552 lupus patients, some taking hydroxychloroquine and some not, during the pandemic. The goal was to see if the drug lowered the risk of infection or reduced serious illness.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID-19 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Haut-Lévêque Hospital - Gastro-entérologie

    Pessac, 33604, France

  • Haut-Lévêque Hospital - Médecine interne

    Pessac, 33604, France

  • Joseph Ducuing Hospital - Médecine interne

    Toulouse, 31027, France

  • Limoges university Hospital

    Limoges, 87042, France

  • Montpellier University Hospital

    Montpellier, 31295, France

  • Pitié Salpêtrière Hospital - Hépatologie

    Paris, 75651, France

  • Pitié Salpêtrière Hospital - Médecine interne

    Paris, 75651, France

  • Toulouse University Hospital

    Toulouse, 31059, France

  • Toulouse University Hospital - Rhumatologie

    Toulouse, 31059, France

  • Toulouse university Hospital - Larrey Dermatologie

    Toulouse, 31059, France

  • University Hospital of Toulouse - Rangueil Médecine interne

    Toulouse, 31059, France

  • University hospital Toulouse - Purpan Médecine interne

    Toulouse, 31059, France

Conditions

Explore the condition pages connected to this study.